Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 46 AL 60

The foundation and architecture of precision medicine in neurology and psychiatry

Hampel H, Gao P, Cummings J, Toschi N, Thompson PM, Hu Y, Cho M, Vergallo A.

Trends Neurosci. 2023 Mar;46(3):176-198. doi: 10.1016/j.tins.2022.12.004. Epub 2023 Jan 13.

Alzheimer's disease and synapse Loss: What can we learn from induced pluripotent stem Cells?

Rodriguez-Jimenez FJ, Ureña-Peralta J, Jendelova P, Erceg S.

J Adv Res. 2023 Dec;54:105-118. doi: 10.1016/j.jare.2023.01.006. Epub 2023 Jan 14.

Role of angiotensin receptor blockers in the context of Alzheimer's disease

Kuber B, Fadnavis M, Chatterjee B.

Fundam Clin Pharmacol. 2023 Jun;37(3):429-445. doi: 10.1111/fcp.12872. Epub 2023 Jan 26.

Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: agitation and weight loss

Palmieri B, Vadalà M.

Clin Ter. 2023 Jan-Feb;174(1):53-60. doi: 10.7417/CT.2023.5009.

Application of Marine Natural Products against Alzheimer's Disease: Past, Present and Future

Hu D, Jin Y, Hou X, Zhu Y, Chen D, Tai J, Chen Q, Shi C, Ye J, Wu M, Zhang H, Lu Y.

Mar Drugs. 2023 Jan 5;21(1):43. doi: 10.3390/md21010043.

Metal Complexes as Promising Matrix Metalloproteinases Regulators

Nguyen YT, Kim N, Lee HJ.

Int J Mol Sci. 2023 Jan 9;24(2):1258. doi: 10.3390/ijms24021258.

Tacrine-Based Hybrids: Past, Present, and Future

Bubley A, Erofeev A, Gorelkin P, Beloglazkina E, Majouga A, Krasnovskaya O.

Int J Mol Sci. 2023 Jan 15;24(2):1717. doi: 10.3390/ijms24021717.

Tau, tau kinases, and tauopathies: An updated overview

Montalto G, Ricciarelli R.

Biofactors. 2023 May-Jun;49(3):502-511. doi: 10.1002/biof.1930. Epub 2023 Jan 23.

Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease

Chaudhari V, Bagwe-Parab S, Buttar HS, Gupta S, Vora A, Kaur G.

Neurotox Res. 2023 Jun;41(3):270-287. doi: 10.1007/s12640-023-00634-7. Epub 2023 Jan 27.

Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

Gu L, Ju Y, Hu M, Zheng M, Li Q, Zhang X.

Metab Brain Dis. 2023 Mar;38(3):839-854. doi: 10.1007/s11011-022-01139-6. Epub 2023 Feb 1.

Clinical efficacy and safety of compound Congrong Yizhi Capsules on Alzheimer's disease in mainland China: A systematic review with trial sequential analysis and GRADE assessment

Wang Y, Wang N, Xu Z, Liu S, Liang X, Zhang Y, Jin X.

J Ethnopharmacol. 2023 Jun 12;309:116208. doi: 10.1016/j.jep.2023.116208. Epub 2023 Jan 31.

An insight into the TAM system in Alzheimer's disease

Zhou S, Li Y, Zhang Z, Yuan Y.

Int Immunopharmacol. 2023 Mar;116:109791. doi: 10.1016/j.intimp.2023.109791. Epub 2023 Feb 2.

Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease

Sharma A, Piplani P.

Curr Top Med Chem. 2023;23(13):1260-1276. doi: 10.2174/1568026623666230203141543.

Treatment of Alzheimer's Disease: Contemporary Perspectives in Medicinal Chemistry

de Oliveira AS.

Curr Med Chem. 2023;30(6):667-668. doi: 10.2174/092986733006221208094952.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias